Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 192 entries
Sorted by: Best Match Show Resources per page
Methyl 3,5-bis-[(4-hydroxy-methyl-2-methoxy-phen-oxy)meth-yl]benzoate.

Acta crystallographica. Section E, Structure reports online

Arshad MN, Mough ST, Goeltz JC, Holman KT.
PMID: 21580441
Acta Crystallogr Sect E Struct Rep Online. 2010 Feb 27;66:o703. doi: 10.1107/S160053681000677X.

In the title compound, C(26)H(28)O(8), the central aromatic ring forms dihedral angles of 24.32 (11) and 80.19 (7)° with the two adjoining vanillyl alcohol rings. In the crystal, O-H⋯O hydrogen bonds connect the mol-ecules, forming a hydrogen-bonded sheet-like motif...

Cite
Arshad MN, Mough ST, Goeltz JC, et al. Methyl 3,5-bis-[(4-hydroxy-methyl-2-methoxy-phen-oxy)meth-yl]benzoate. Acta Crystallogr Sect E Struct Rep Online. 2010;66:o703doi: 10.1107/S160053681000677X.
Arshad, M. N., Mough, S. T., Goeltz, J. C., & Holman, K. T. (2010). Methyl 3,5-bis-[(4-hydroxy-methyl-2-methoxy-phen-oxy)meth-yl]benzoate. Acta crystallographica. Section E, Structure reports online, 66o703. https://doi.org/10.1107/S160053681000677X
Arshad, Muhammad Nadeem, et al. "Methyl 3,5-bis-[(4-hydroxy-methyl-2-methoxy-phen-oxy)meth-yl]benzoate." Acta crystallographica. Section E, Structure reports online vol. 66 (2010): o703. doi: https://doi.org/10.1107/S160053681000677X
Arshad MN, Mough ST, Goeltz JC, Holman KT. Methyl 3,5-bis-[(4-hydroxy-methyl-2-methoxy-phen-oxy)meth-yl]benzoate. Acta Crystallogr Sect E Struct Rep Online. 2010 Feb 27;66:o703. doi: 10.1107/S160053681000677X. PMID: 21580441; PMCID: PMC2983507.
Copy Download .nbib Format: NLM
What shall I be, what must I be: neural correlates of personal goal activation.

Frontiers in integrative neuroscience

Strauman TJ, Detloff AM, Sestokas R, Smith DV, Goetz EL, Rivera C, Kwapil L.
PMID: 23316145
Front Integr Neurosci. 2013 Jan 07;6:123. doi: 10.3389/fnint.2012.00123. eCollection 2012.

How is the brain engaged when people are thinking about their hopes, dreams, and obligations? Regulatory focus theory postulates two classes of personal goals and motivational systems for pursuing them. Ideal goals, such as hopes and aspirations, are pursued...

Cite
Strauman TJ, Detloff AM, Sestokas R, et al. What shall I be, what must I be: neural correlates of personal goal activation. Front Integr Neurosci. 2013;6:123doi: 10.3389/fnint.2012.00123.
Strauman, T. J., Detloff, A. M., Sestokas, R., Smith, D. V., Goetz, E. L., Rivera, C., & Kwapil, L. (2012). What shall I be, what must I be: neural correlates of personal goal activation. Frontiers in integrative neuroscience, 6123. https://doi.org/10.3389/fnint.2012.00123
Strauman, Timothy J, et al. "What shall I be, what must I be: neural correlates of personal goal activation." Frontiers in integrative neuroscience vol. 6 (2012): 123. doi: https://doi.org/10.3389/fnint.2012.00123
Strauman TJ, Detloff AM, Sestokas R, Smith DV, Goetz EL, Rivera C, Kwapil L. What shall I be, what must I be: neural correlates of personal goal activation. Front Integr Neurosci. 2013 Jan 07;6:123. doi: 10.3389/fnint.2012.00123. eCollection 2012. PMID: 23316145; PMCID: PMC3539852.
Copy Download .nbib Format: NLM
The role of prostaglandins in the control of ovulation in yellow perch,Perca flavescens.

Fish physiology and biochemistry

Goetz FW, Duman P, Berndtson A, Janowsky EG.
PMID: 24221768
Fish Physiol Biochem. 1989 Jun;7(1):163-8. doi: 10.1007/BF00004703.

Previous studies have shown that 17α,20β-dihydroxy-4-pregnen-3-one (17α,20β-P) can induce both germinal vesicle breakdown and ovulationin vitro of yellow perch (Perca flavescens) oocytes. The stimulation of ovulation can be blocked by indomethacin and restored by the subsequent addition of several...

Cite
Goetz FW, Duman P, Berndtson A, et al. The role of prostaglandins in the control of ovulation in yellow perch,Perca flavescens. Fish Physiol Biochem. 1989;7(1):163-8doi: 10.1007/BF00004703.
Goetz, F. W., Duman, P., Berndtson, A., & Janowsky, E. G. (1989). The role of prostaglandins in the control of ovulation in yellow perch,Perca flavescens. Fish physiology and biochemistry, 7(1), 163-8. https://doi.org/10.1007/BF00004703
Goetz, F W, et al. "The role of prostaglandins in the control of ovulation in yellow perch,Perca flavescens." Fish physiology and biochemistry vol. 7,1 (1989): 163-8. doi: https://doi.org/10.1007/BF00004703
Goetz FW, Duman P, Berndtson A, Janowsky EG. The role of prostaglandins in the control of ovulation in yellow perch,Perca flavescens. Fish Physiol Biochem. 1989 Jun;7(1):163-8. doi: 10.1007/BF00004703. PMID: 24221768.
Copy Download .nbib Format: NLM
Oncolytic poliovirus against malignant glioma.

Future virology

Goetz C, Dobrikova E, Shveygert M, Dobrikov M, Gromeier M.
PMID: 21984883
Future Virol. 2011 Sep;6(9):1045-1058. doi: 10.2217/fvl.11.76.

In cancerous cells, physiologically tight regulation of protein synthesis is lost, contributing to uncontrolled growth and proliferation. We describe a novel experimental cancer therapy approach based on genetically recombinant poliovirus that targets an intriguing aberration of translation control in...

Cite
Goetz C, Dobrikova E, Shveygert M, et al. Oncolytic poliovirus against malignant glioma. Future Virol. 2011;6(9):1045-1058doi: 10.2217/fvl.11.76.
Goetz, C., Dobrikova, E., Shveygert, M., Dobrikov, M., & Gromeier, M. (2011). Oncolytic poliovirus against malignant glioma. Future virology, 6(9), 1045-1058. https://doi.org/10.2217/fvl.11.76
Goetz, Christian, et al. "Oncolytic poliovirus against malignant glioma." Future virology vol. 6,9 (2011): 1045-1058. doi: https://doi.org/10.2217/fvl.11.76
Goetz C, Dobrikova E, Shveygert M, Dobrikov M, Gromeier M. Oncolytic poliovirus against malignant glioma. Future Virol. 2011 Sep;6(9):1045-1058. doi: 10.2217/fvl.11.76. PMID: 21984883; PMCID: PMC3187927.
Copy Download .nbib Format: NLM
Reply.

Cornea

Perone JM, Goetz C, Lhuillier L.
PMID: 29300269
Cornea. 2018 Apr;37(4):e20. doi: 10.1097/ICO.0000000000001494.

No abstract available.

Cite
Perone JM, Goetz C, Lhuillier L. Reply. Cornea. 2018;37(4):e20doi: 10.1097/ICO.0000000000001494.
Perone, J. M., Goetz, C., & Lhuillier, L. (2018). Reply. Cornea, 37(4), e20. https://doi.org/10.1097/ICO.0000000000001494
Perone, Jean Marc, et al. "Reply." Cornea vol. 37,4 (2018): e20. doi: https://doi.org/10.1097/ICO.0000000000001494
Perone JM, Goetz C, Lhuillier L. Reply. Cornea. 2018 Apr;37(4):e20. doi: 10.1097/ICO.0000000000001494. PMID: 29300269.
Copy Download .nbib Format: NLM
Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale.

Movement disorders clinical practice

Akbostanci MC, Bayram E, Yilmaz V, Rzayev S, Özkan S, Tokcaer AB, Saka E, Durmaz Celik FN, Barut BÖ, Tüfekcioglu Z, Acarer A, Balaban H, Erer S, Dogu O, Kibaroglu S, Aydin N, Hanagasi H, Elibol B, Emre M, Stebbins GT, Goetz CG.
PMID: 30363359
Mov Disord Clin Pract. 2017 Nov 16;5(1):54-59. doi: 10.1002/mdc3.12556. eCollection 2018.

BACKGROUND: Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Unified Dyskinesia Rating Scale (UDysRS) were developed as standard tools to rate Parkinson's disease (PD) and drug-induced dyskinesias of PD. As these scales have become widely used, there...

Cite
Akbostanci MC, Bayram E, Yilmaz V, et al. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. Mov Disord Clin Pract. 2017;5(1):54-59doi: 10.1002/mdc3.12556.
Akbostanci, M. C., Bayram, E., Yilmaz, V., Rzayev, S., Özkan, S., Tokcaer, A. B., Saka, E., Durmaz Celik, F. N., Barut, B. �. �., Tüfekcioglu, Z., Acarer, A., Balaban, H., Erer, S., Dogu, O., Kibaroglu, S., Aydin, N., Hanagasi, H., Elibol, B., Emre, M., Stebbins, G. T., & Goetz, C. G. (2018). Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. Movement disorders clinical practice, 5(1), 54-59. https://doi.org/10.1002/mdc3.12556
Akbostanci, Muhittin C, et al. "Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale." Movement disorders clinical practice vol. 5,1 (2018): 54-59. doi: https://doi.org/10.1002/mdc3.12556
Akbostanci MC, Bayram E, Yilmaz V, Rzayev S, Özkan S, Tokcaer AB, Saka E, Durmaz Celik FN, Barut BÖ, Tüfekcioglu Z, Acarer A, Balaban H, Erer S, Dogu O, Kibaroglu S, Aydin N, Hanagasi H, Elibol B, Emre M, Stebbins GT, Goetz CG. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. Mov Disord Clin Pract. 2017 Nov 16;5(1):54-59. doi: 10.1002/mdc3.12556. eCollection 2018. PMID: 30363359; PMCID: PMC6174365.
Copy Download .nbib Format: NLM
Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure.

Journal of pancreatic cancer

Bauer TM, Dhir T, Strickland A, Thomsett H, Goetz AB, Cannaday S, Brody JR, Pishvaian MJ, Yeo CJ.
PMID: 30788462
J Pancreat Cancer. 2018 Nov 01;4(1):81-87. doi: 10.1089/pancan.2018.0015. eCollection 2018.

No abstract available.

Cite
Bauer TM, Dhir T, Strickland A, et al. Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure. J Pancreat Cancer. 2018;4(1):81-87doi: 10.1089/pancan.2018.0015.
Bauer, T. M., Dhir, T., Strickland, A., Thomsett, H., Goetz, A. B., Cannaday, S., Brody, J. R., Pishvaian, M. J., & Yeo, C. J. (2018). Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure. Journal of pancreatic cancer, 4(1), 81-87. https://doi.org/10.1089/pancan.2018.0015
Bauer, Tyler M, et al. "Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure." Journal of pancreatic cancer vol. 4,1 (2018): 81-87. doi: https://doi.org/10.1089/pancan.2018.0015
Bauer TM, Dhir T, Strickland A, Thomsett H, Goetz AB, Cannaday S, Brody JR, Pishvaian MJ, Yeo CJ. Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure. J Pancreat Cancer. 2018 Nov 01;4(1):81-87. doi: 10.1089/pancan.2018.0015. eCollection 2018. PMID: 30788462; PMCID: PMC6371588.
Copy Download .nbib Format: NLM
Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale.

Movement disorders clinical practice

Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, Zhang L, Leehey MA.
PMID: 30838310
Mov Disord Clin Pract. 2019 Jan 22;6(2):120-124. doi: 10.1002/mdc3.12708. eCollection 2019 Feb.

BACKGROUND: There are currently no proven treatments for fragile X-associated tremor and ataxia syndrome (FXTAS). Validated outcome measures are needed in order to plan and conduct clinical trials to aid in the development of therapy.METHODS: This study examined the...

Cite
Hall DA, Stebbins GT, Jacquemont S, et al. Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Mov Disord Clin Pract. 2019;6(2):120-124doi: 10.1002/mdc3.12708.
Hall, D. A., Stebbins, G. T., Jacquemont, S., Berry-Kravis, E., Goetz, C. G., Hagerman, R., Zhang, L., & Leehey, M. A. (2019). Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Movement disorders clinical practice, 6(2), 120-124. https://doi.org/10.1002/mdc3.12708
Hall, Deborah A, et al. "Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale." Movement disorders clinical practice vol. 6,2 (2019): 120-124. doi: https://doi.org/10.1002/mdc3.12708
Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, Zhang L, Leehey MA. Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Mov Disord Clin Pract. 2019 Jan 22;6(2):120-124. doi: 10.1002/mdc3.12708. eCollection 2019 Feb. PMID: 30838310; PMCID: PMC6384171.
Copy Download .nbib Format: NLM
How Do I Test for Postural Stability?.

Movement disorders clinical practice

Goetz CG, Vittal P, Maldonado J.
PMID: 30868091
Mov Disord Clin Pract. 2014 May 21;1(2):144. doi: 10.1002/mdc3.12029. eCollection 2014 Jun.

One of the core elements of Parkinson's disease is postural reflex compromise. To test postural stability, the International Parkinson and Movement Disorder Society revision of the UPDRS (MDS-UPDRS) provides very specific instructions for uniform and safe testing. Item 3.12...

Cite
Goetz CG, Vittal P, Maldonado J. How Do I Test for Postural Stability?. Mov Disord Clin Pract. 2014;1(2):144doi: 10.1002/mdc3.12029.
Goetz, C. G., Vittal, P., & Maldonado, J. (2014). How Do I Test for Postural Stability?. Movement disorders clinical practice, 1(2), 144. https://doi.org/10.1002/mdc3.12029
Goetz, Christopher G, et al. "How Do I Test for Postural Stability?." Movement disorders clinical practice vol. 1,2 (2014): 144. doi: https://doi.org/10.1002/mdc3.12029
Goetz CG, Vittal P, Maldonado J. How Do I Test for Postural Stability?. Mov Disord Clin Pract. 2014 May 21;1(2):144. doi: 10.1002/mdc3.12029. eCollection 2014 Jun. PMID: 30868091; PMCID: PMC6407063.
Copy Download .nbib Format: NLM
Structural correlates of atypical visual and motor cortical oscillations in pediatric-onset multiple sclerosis.

Human brain mapping

Waldman AT, Sollee JR, Datta R, Lavery AM, Liu G, Aleman TS, Banwell BL, Gaetz WC.
PMID: 32648649
Hum Brain Mapp. 2020 Oct 15;41(15):4299-4313. doi: 10.1002/hbm.25126. Epub 2020 Jul 10.

We have previously demonstrated that pediatric-onset multiple sclerosis (POMS) negatively impacts the visual pathway as well as motor processing speed. Relationships between MS-related diffuse structural damage of gray and white matter (WM) tissue and cortical responses to visual and...

Cite
Waldman AT, Sollee JR, Datta R, et al. Structural correlates of atypical visual and motor cortical oscillations in pediatric-onset multiple sclerosis. Hum Brain Mapp. 2020;41(15):4299-4313doi: 10.1002/hbm.25126.
Waldman, A. T., Sollee, J. R., Datta, R., Lavery, A. M., Liu, G., Aleman, T. S., Banwell, B. L., & Gaetz, W. C. (2020). Structural correlates of atypical visual and motor cortical oscillations in pediatric-onset multiple sclerosis. Human brain mapping, 41(15), 4299-4313. https://doi.org/10.1002/hbm.25126
Waldman, Amy T, et al. "Structural correlates of atypical visual and motor cortical oscillations in pediatric-onset multiple sclerosis." Human brain mapping vol. 41,15 (2020): 4299-4313. doi: https://doi.org/10.1002/hbm.25126
Waldman AT, Sollee JR, Datta R, Lavery AM, Liu G, Aleman TS, Banwell BL, Gaetz WC. Structural correlates of atypical visual and motor cortical oscillations in pediatric-onset multiple sclerosis. Hum Brain Mapp. 2020 Oct 15;41(15):4299-4313. doi: 10.1002/hbm.25126. Epub 2020 Jul 10. PMID: 32648649; PMCID: PMC7502834.
Copy Download .nbib Format: NLM
Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Movement disorders clinical practice

Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT.
PMID: 30515437
Mov Disord Clin Pract. 2018 Oct 25;5(5):479-491. doi: 10.1002/mdc3.12636. eCollection 2018.

BACKGROUND: The prevalence of lower urinary tract symptoms (LUTS) is high in Parkinson's disease (PD). These problems negatively affect quality of life and include both storage and voiding problems. The International Parkinson and Movement Disorder Society established a task...

Cite
Pavy-Le Traon A, Cotterill N, Amarenco G, et al. Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018;5(5):479-491doi: 10.1002/mdc3.12636.
Pavy-Le Traon, A., Cotterill, N., Amarenco, G., Duerr, S., Kaufmann, H., Lahrmann, H., Tison, F., Wenning, G. K., Goetz, C. G., Poewe, W., Sampaio, C., Schrag, A., Rascol, O., Martinez-Martin, P., Stebbins, G. T. (2018). Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations. Movement disorders clinical practice, 5(5), 479-491. https://doi.org/10.1002/mdc3.12636
Pavy-Le Traon, Anne, et al. "Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations." Movement disorders clinical practice vol. 5,5 (2018): 479-491. doi: https://doi.org/10.1002/mdc3.12636
Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT. Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018 Oct 25;5(5):479-491. doi: 10.1002/mdc3.12636. eCollection 2018. PMID: 30515437; PMCID: PMC6207119.
Copy Download .nbib Format: NLM
The clonal evolution of metastatic colorectal cancer.

Science advances

Dang HX, Krasnick BA, White BS, Grossman JG, Strand MS, Zhang J, Cabanski CR, Miller CA, Fulton RS, Goedegebuure SP, Fronick CC, Griffith M, Larson DE, Goetz BD, Walker JR, Hawkins WG, Strasberg SM, Linehan DC, Lim KH, Lockhart AC, Mardis ER, Wilson RK, Ley TJ, Maher CA, Fields RC.
PMID: 32577507
Sci Adv. 2020 Jun 10;6(24):eaay9691. doi: 10.1126/sciadv.aay9691. eCollection 2020 Jun.

Tumor heterogeneity and evolution drive treatment resistance in metastatic colorectal cancer (mCRC). Patient-derived xenografts (PDXs) can model mCRC biology; however, their ability to accurately mimic human tumor heterogeneity is unclear. Current genomic studies in mCRC have limited scope and...

Cite
Dang HX, Krasnick BA, White BS, et al. The clonal evolution of metastatic colorectal cancer. Sci Adv. 2020;6(24):eaay9691doi: 10.1126/sciadv.aay9691.
Dang, H. X., Krasnick, B. A., White, B. S., Grossman, J. G., Strand, M. S., Zhang, J., Cabanski, C. R., Miller, C. A., Fulton, R. S., Goedegebuure, S. P., Fronick, C. C., Griffith, M., Larson, D. E., Goetz, B. D., Walker, J. R., Hawkins, W. G., Strasberg, S. M., Linehan, D. C., Lim, K. H., Lockhart, A. C., Mardis, E. R., Wilson, R. K., Ley, T. J., Maher, C. A., & Fields, R. C. (2020). The clonal evolution of metastatic colorectal cancer. Science advances, 6(24), eaay9691. https://doi.org/10.1126/sciadv.aay9691
Dang, Ha X, et al. "The clonal evolution of metastatic colorectal cancer." Science advances vol. 6,24 (2020): eaay9691. doi: https://doi.org/10.1126/sciadv.aay9691
Dang HX, Krasnick BA, White BS, Grossman JG, Strand MS, Zhang J, Cabanski CR, Miller CA, Fulton RS, Goedegebuure SP, Fronick CC, Griffith M, Larson DE, Goetz BD, Walker JR, Hawkins WG, Strasberg SM, Linehan DC, Lim KH, Lockhart AC, Mardis ER, Wilson RK, Ley TJ, Maher CA, Fields RC. The clonal evolution of metastatic colorectal cancer. Sci Adv. 2020 Jun 10;6(24):eaay9691. doi: 10.1126/sciadv.aay9691. eCollection 2020 Jun. PMID: 32577507; PMCID: PMC7286679.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 192 entries